How will COVID-19 affect the MSL role and what new skills may emerge as necessary to maintain value, access and future succes
My guest today is Paul Ward. He is the National Director, Oncology MSLs at AstraZeneca, and MSL Society Advisory Board Member. We will discuss how Covid-19 will affect the role of the MSL and what new skills may emerge as necessary to maintain value, access, and future success.